SlideShare a Scribd company logo
1 of 36
IMPROVING HEALTH LITERACY:
  What is the evidence ?

  Kirsten McCaffery PhD
  kirsten.mccaffery@sydney.edu.au


SYDNEY MEDICAL SCHOOL



                            Screening and Test Evaluation Program (STEP)
                         Centre for Medical Psychology and Evidence-based
                                                Decision Making (CeMPED)
IMPROVING HEALTH LITERACY

 Substantial research linking low health literacy with poor
  health
 Intervention health literacy research is less well
  developed
 3 systematic reviews of health literacy interventions but
  findings mixed (Pignone JGIM 2005, Coulter & Ellins
  BMJ 2007, Clement et al PEC 2009)
 However, there IS evidence to guide policy and practice
  now
 Evidence from low literacy and general population
  samples
IMPROVING HEALTH LITERACY


Two key areas for evidence-based action:


1. To improve health communication


2. To support patient involvement
IMPROVING HEALTH LITERACY


Two key areas for evidence-based action:


1. To improve health communication


2. To support patient involvement
IMPROVING HEALTH LITERACY


There is good quality evidence to support strategies
  to improve :
    a. Written health information – use plain language guides

    b. Prescription drug labels – use precise instructions

    c. Verbal communication – use β€˜teach back’ method

    d. Risk communication
IMPROVING HEALTH LITERACY


There is good quality evidence to support strategies
  to improve :
    a. Written health information – use plain language guides

    b. Prescription drug labels – use precise instructions

    c. Verbal communication – use β€˜teach back’ method

    d. Risk communication
RISK COMMUNICATION




  Use natural
  frequencies

  5 out of 100
women will require
   additional
   treatment


                     Gigerenzer et al 1995, Feldman-Stewart et al
                     2000, Fagerlin et al review 2007
RISK COMMUNICATION

  Of 100 women who
     have surgery
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●




5 out of 100 women
will require additional
       treatment          Gigerenzer et al 1995, Feldman-Stewart et al
                          2000, Fagerlin et al review 2007
RISK COMMUNICATION

  Of 100 women who                    20% less women will
     have surgery                     required additional
                                      treatment
                                      5% of women will
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
                          NOT         required additional
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●

                                      treatment
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●




5 out of 100 women
will require additional
       treatment           Gigerenzer et al 1995, Feldman-Stewart et al
                           2000, Fagerlin et al review 2007
RISK COMMUNICATION

  Of 100 women who                    20% less women will
     have surgery                     required additional
                                      treatment
                                      5% of women will
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
                          NOT         required additional
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●

                                      treatment
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●




                                                    OR
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●
  ●




                                      100
                                       90
                                       80
                                       70
                                       60
                                       50
                                       40
                                       30

5 out of 100 women                     20
                                       10
                                        0

will require additional
       treatment           Gigerenzer et al 1995, Feldman-Stewart et al
                           2000, Fagerlin et al review 2007
RISK COMMUNICATION

Medical risk training for low and high SES
  consumers

Woloshin et al Annals Intern Med 2007
 Education package to improve understanding of risk
   messages in the media and health statistics
 2 RCTs among low and high SES consumers
 Medical risk primer vs general health booklet (control)
 Examined impact using knowledge test
RISK COMMUNICATION

Impact of the primer on understanding

Patient group   Control gp    Risk Primer    % Difference       Significance
                β€˜pass rate’   β€˜pass rate’     (95% CIs)




                                                            Pass β‰₯ 75 / 100 correct
RISK COMMUNICATION

Impact of the primer on understanding

Patient group   Control gp    Risk Primer    % Difference       Significance
                β€˜pass rate’   β€˜pass rate’     (95% CIs)
Low SES            26%           44%             18%                p<0.01
n= 221                                         (8-28%)




                                                            Pass β‰₯ 75 / 100 correct
RISK COMMUNICATION

Impact of the primer on understanding

Patient group   Control gp    Risk Primer    % Difference       Significance
                β€˜pass rate’   β€˜pass rate’     (95% CIs)
Low SES            26%           44%             18%                p<0.01
n= 221                                         (8-28%)
High SES           56%           74%             18%               p<0.001
n=334                                          (5-31%)

                                                            Pass β‰₯ 75 / 100 correct
RISK COMMUNICATION

Impact of the primer on understanding

Patient group   Control gp    Risk Primer    % Difference       Significance
                β€˜pass rate’   β€˜pass rate’     (95% CIs)
Low SES            26%           44%             18%                p<0.01
n= 221                                         (8-28%)
High SES           56%           74%             18%               p<0.001
n=334                                          (5-31%)

                                                            Pass β‰₯ 75 / 100 correct
RISK COMMUNICATION

Impact of the primer on understanding

Patient group    Control gp      Risk Primer    % Difference       Significance
                 β€˜pass rate’     β€˜pass rate’      (95% CIs)
Low SES             26%              44%             18%               p<0.01
n= 221                                             (8-28%)
High SES            56%              74%             18%              p<0.001
n=334                                              (5-31%)

                                                               Pass β‰₯ 75 / 100 correct

  Interest in medical statistics significantly increased in both groups
  Low SES = + 8 points (p=0.004)
  High SES = + 6 points (p=0.004)
IMPROVING HEALTH LITERACY

Two key areas for evidence based action:

1. To improve health communication


2. To support patient involvement

    β€’ Broader definition of health literacy (asset)
    β€’ Fits within model of Patient Centred Care and
      Shared Decision Making
    β€’ Highlighted in National Health Hospital Reform
      Commission Report
IMPROVING HEALTH LITERACY


Effective tools are available to support patient
   involvement and engagement in healthcare.
2 main types:
    a. Patient Decision Aids

    b. Intervention to promote question asking (Question
      Prompt Lists (QPL) / patient coaching)
PATIENT DECISION AIDS

What are patient decision aids?
 Information designed to help patients make an informed
  choice consistent with their preferences
 Booklet / video/ audio / web-based form
 Include evidence based information on options
  and outcomes
 Exercises to help patients clarify values
PATIENT DECISION AIDS

Patient decision aids are very effective.
Systematic review of 55 DA trials showed DAs:

      Improve patient knowledge and understanding of
       risks and benefits

      Increase realistic expectations of outcomes

      Reduce uncertainty in decision making

      Increase consistency between patients’ values and
       choice

      Without increasing in patient anxiety
PATIENT DECISION AIDS


In some circumstances decision aids:

 Increase adherence

 Reduce unnecessary testing/ medical procedures

 Increase quality of life

                     (O’Connor et al. Cochrane Review 2009)
QUESTION ASKING INTERVENTIONS

What are Question Asking Interventions?
Interventions to encourage patients to ask questions and direct
the content of the consultation towards their needs and
concerns
QUESTION ASKING INTERVENTIONS

What are Question Asking Interventions?
Interventions to encourage patients to ask questions and direct
the content of the consultation towards their needs and
concerns
QUESTION ASKING INTERVENTIONS

Kinnersley et al Cochrane review (2007)

Question Asking Interventions
 Increased question asking
 Increased patient satisfaction (small increase)
 No increase in anxiety
 No increase in consultation length

In some studies QPLs
 Enabled participants to raise more β€˜sensitive’ issues
  during the consultation (Clayton et al 2007)
INVOLVING LOW LITERACY PATIENTS


 Excellent evidence that DAs and QPLs support patient
  involvement and improve health decisions
 But very little research with low literacy and low
  education groups
 These groups are least involved in healthcare, most
  difficult to get to participate, form large % patient
  population
 However, we recently completed a RCT β€˜lower literacy’
  DA among adults with low education
FOBT SCREENING LOWER LITERACY DA
McCaffery et al NHMRC project grant, Sian Smith et al PhD. [Full project team: K
McCaffery, S Smith, L Trevena, A Barratt, J Simpson, D Nutbeam]
Trial design


                                      Community sample:
                                      adults 55-64 years
                                            n= 585
                                    Lower education levels*


                                                              Control:
                     Decision Aid
                                                     Govt screening booklet
                 FOBT screening kit
                                                         FOBT screening kit




                                           Knowledge
                                        Informed choice                  2 weeks
* No formal educ                 Involvement in decision making
qualifications, intermediate         Psychosocial outcomes
school certificate, technical/
trade qualification

                                      Screening behaviour                3 months
                                       (FOBT completion)
Low education/ literacy DA trial: results


 DA increased adequate knowledge by 38%
  (56% DAs vs control 18%)
 DA increased in informed choice by 22%
  (adequate knowledge, choice consistent with attitudes
  34% DA vs 12% control)
 DA increased preferences for shared decision making
  (P=0.04)
 No difference in uncertainty in decision making and
  anxiety - low in both groups
 Acceptability of DA high (>90%)
                                 (Smith et al BMJ under review)
CONCLUSIONS

 Possible to design DAs to help low education / low health
  literacy consumers make informed choices
 Even though this involves communicating complicated
  medical information
 More research supporting patient involvement in low health
  literacy groups
 Although field is rapidly developing, evidence available to
  support action now:
     οƒΌ Written health communication
     οƒΌ Prescription drug labels
     οƒΌ Verbal communication
     οƒΌ Risk communication
     οƒΌ Supporting patient involvement
Goal for Public Health & Medicine




Patient skills                                      Evidence
      +                                                 +
Health system        CLOSE THE GAP                  Practice




                 Particular thanks to: Sian Smith
EFFECTIVE HEALTH COMMUNICATION
Prescription drug labels
 US study of 400 native English speaking primary care
  patients, lower SES.
      50% misunderstood commonly used prescription labels (Davies et al
       Archives 2006)
 Understanding improved 53% - 89% correct, if instructions
  are precise and explicit (Davies et al JGIM 2008)
 E.g.
      β€˜Take at 6am and 6pm’ or
      β€˜take 1 with breakfast and 1 with supper’
 NOT β€˜take twice daily’ or β€˜take every 12 hours’
CONSUMERS / PATIENT NEEDS

So why does SDM matter?:

 Consumers want more health information and
  involvement in health decisions

 European survey of over 8,000 consumers (Coulter
  BJC 2003)

        Over 70% of those surveyed wanted β€˜shared
         decision making’

 In Australia our own work has reported similar high
  levels of interest in SDM in breast treatment and testing
  decisions (Davey, Barratt et al 2002)
IMPROVING HEALTH LITERACY


There is good quality evidence to support strategies
  to improve :
    a. Written health information – use plain language guides

    b. Prescription drug labels – use precise instructions

    c. Verbal communication – use β€˜teach back’ method

    d. Risk communication – natural frequencies
RISK COMMUNICATION


        Key topics
 Risk of what?
 How big is the risk?
 Does the risk information
  reasonably apply to you?
 How does this compare
  to other risks?
 Things you should do to
  better understand risk…..
Trials of cancer screening decision aids (DAs)
   Screening       Countr     Study population and                 Description                 Primary        % Adeq     % Screened        % Informed choice
  context and        y            recruitment                                                 outcomes       knowldge
                                                                                                                        DA vs Control        DA vs Control
   author(s)                                                                                  measured
                                                                                                             DA vs       (difference)         (difference)
                                                                                                             Control
                                                                                                               (diff)

FOBT screening Aus           Men and women aged      DA tailored for adults with lower Knowledge             56 vs 19      59 vs 75            34 vs 12
for bowel cancer            between 55-64 years with education and literacy with
                                                                                       Informed               (38) **       (-16) **            (22) **
(Smith, et al.              lower education levels   government information booklet
                                                                                       choice
2009)
                                                                                            Involvement
                                                                                            in decision
Mammog             Aus       Women aged 70 years or DA with usual care information          Knowledge        77 vs 57       6 vs 7             74 vs 49
screening for               older , regularly       (leaflet developed for breast
                                                                                            Informed          (20) **         (-1)               (25)**
breast cancer               participated in         cancer screening service).
                                                                                            choice
                            mammography screening.
(Mathieu, et al.                                                                   Participation
2007)                                                                              in screening
FOBT screening Aus          Adults aged between 45- DA against standard government Knowledge                  21 vs 6       5 vs 7              10 vs 2
for bowel cancer            74 yrs at GP practice   information booklet.
                                                                                   Informed                   (15)**          (-2)               (8)**
(Trevena et al
                                                                                   choice
2008)

FOBT and           US        Adults aged 65 years and 2 DAs (one relative risk info and Screening            71 vs 54      Intentions             N/A
flexible sig for            older visiting their primary the other with absolute risk infor) interest and
                                                                                                              (17)**      Control: 59;
CRC (Wolf et al             care doctor                  against control message.            intentions
2000)                                                                                                                   Rel risk DA: 67;
                                                                                                                        Abs risk DA: 63
FOBT, flex sig, US           Adults aged 50 years and Compared DA based on multi-           Decisional         N/A         49 vs 52               N/A
barium en,                  older, visiting their primarycriteria decision-making theory    conflict
                                                                                                                              (-3)
colonos for                 care doctor                  with a simple educational
                                                                                            Screening
CRC (Dolan et al                                         intervention.
                                                                                            intentions and
2002)
                                                                                            behaviour

FOBT and           US        Adults aged between 50- Educational video about bowel      Screening              N/A         37 vs 23               N/A
Fleixble sig                75 years from primary    screening with video on            behaviour
                                                                                                                             (14)**
(Pignone et al              care.                    automobile safety (control group).
2000)

More Related Content

Similar to Kirsten McCaffery | Improving health literacy: what's the evidence?

unexplained Recurrent miscarriages .. practical approach
unexplained Recurrent miscarriages .. practical approachunexplained Recurrent miscarriages .. practical approach
unexplained Recurrent miscarriages .. practical approachIftikharsadique
Β 
Post partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccinationPost partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccinationLifecare Centre
Β 
Post partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccinationPost partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccinationLifecare Centre
Β 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statisticsHesham Al-Inany
Β 
Greenwich LifeSciences (GLSI) December 2020
Greenwich LifeSciences (GLSI) December 2020Greenwich LifeSciences (GLSI) December 2020
Greenwich LifeSciences (GLSI) December 2020RedChip Companies, Inc.
Β 
Utilisation des derives de l'artemisinine pendant la grossesse
Utilisation des derives de l'artemisinine pendant la grossesseUtilisation des derives de l'artemisinine pendant la grossesse
Utilisation des derives de l'artemisinine pendant la grossesseInstitut Pasteur de Madagascar
Β 
Bayesian clinical test
Bayesian clinical testBayesian clinical test
Bayesian clinical testGaetan Lion
Β 
Oncotype Dx Mammaprint
Oncotype Dx MammaprintOncotype Dx Mammaprint
Oncotype Dx Mammaprintfondas vakalis
Β 
ABERRATION IN NORMAL DEVELOPMENT AND INVOLUTION
 ABERRATION IN NORMAL DEVELOPMENT AND INVOLUTION ABERRATION IN NORMAL DEVELOPMENT AND INVOLUTION
ABERRATION IN NORMAL DEVELOPMENT AND INVOLUTIONAbino David
Β 
16290 (10) benign and malignant disease of the breast
16290 (10) benign and malignant disease of the breast16290 (10) benign and malignant disease of the breast
16290 (10) benign and malignant disease of the breastBratasenaDanapati
Β 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septLifecare Centre
Β 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Lifecare Centre
Β 
10.1111_codi.13147 (1)
10.1111_codi.13147 (1)10.1111_codi.13147 (1)
10.1111_codi.13147 (1)roja qobadi
Β 
Impact of Hormonal Contraceptive use upon Women's Social Relationship who att...
Impact of Hormonal Contraceptive use upon Women's Social Relationship who att...Impact of Hormonal Contraceptive use upon Women's Social Relationship who att...
Impact of Hormonal Contraceptive use upon Women's Social Relationship who att...iosrjce
Β 
Female infertility sp
Female infertility spFemale infertility sp
Female infertility spKriti Thapa
Β 
infertility evaluation in detail speroff
infertility evaluation in detail speroffinfertility evaluation in detail speroff
infertility evaluation in detail speroffDrMamathaPaleti1
Β 
RCT Critical Appraisal - Results
RCT Critical Appraisal - ResultsRCT Critical Appraisal - Results
RCT Critical Appraisal - ResultsDr. Majdi Al Jasim
Β 
AN OPPORTUNITY FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
AN OPPORTUNITY  FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre AN OPPORTUNITY  FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
AN OPPORTUNITY FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre Lifecare Centre
Β 

Similar to Kirsten McCaffery | Improving health literacy: what's the evidence? (20)

Improving compliance of applying fall risk precautions
Improving compliance of applying fall risk precautionsImproving compliance of applying fall risk precautions
Improving compliance of applying fall risk precautions
Β 
unexplained Recurrent miscarriages .. practical approach
unexplained Recurrent miscarriages .. practical approachunexplained Recurrent miscarriages .. practical approach
unexplained Recurrent miscarriages .. practical approach
Β 
Post partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccinationPost partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccination
Β 
Post partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccinationPost partum period an excellent opportunity for hpv vaccination
Post partum period an excellent opportunity for hpv vaccination
Β 
Why to know statistics
Why to know statisticsWhy to know statistics
Why to know statistics
Β 
Greenwich LifeSciences (GLSI) December 2020
Greenwich LifeSciences (GLSI) December 2020Greenwich LifeSciences (GLSI) December 2020
Greenwich LifeSciences (GLSI) December 2020
Β 
Utilisation des derives de l'artemisinine pendant la grossesse
Utilisation des derives de l'artemisinine pendant la grossesseUtilisation des derives de l'artemisinine pendant la grossesse
Utilisation des derives de l'artemisinine pendant la grossesse
Β 
Bayesian clinical test
Bayesian clinical testBayesian clinical test
Bayesian clinical test
Β 
Oncotype Dx Mammaprint
Oncotype Dx MammaprintOncotype Dx Mammaprint
Oncotype Dx Mammaprint
Β 
ABERRATION IN NORMAL DEVELOPMENT AND INVOLUTION
 ABERRATION IN NORMAL DEVELOPMENT AND INVOLUTION ABERRATION IN NORMAL DEVELOPMENT AND INVOLUTION
ABERRATION IN NORMAL DEVELOPMENT AND INVOLUTION
Β 
16290 (10) benign and malignant disease of the breast
16290 (10) benign and malignant disease of the breast16290 (10) benign and malignant disease of the breast
16290 (10) benign and malignant disease of the breast
Β 
Cervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th septCervical cancer screening guidelines 2013 on 7th sept
Cervical cancer screening guidelines 2013 on 7th sept
Β 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013
Β 
10.1111_codi.13147 (1)
10.1111_codi.13147 (1)10.1111_codi.13147 (1)
10.1111_codi.13147 (1)
Β 
UOG Journal Club: Diagnostic accuracy of placental growth factor and ultrasou...
UOG Journal Club: Diagnostic accuracy of placental growth factor and ultrasou...UOG Journal Club: Diagnostic accuracy of placental growth factor and ultrasou...
UOG Journal Club: Diagnostic accuracy of placental growth factor and ultrasou...
Β 
Impact of Hormonal Contraceptive use upon Women's Social Relationship who att...
Impact of Hormonal Contraceptive use upon Women's Social Relationship who att...Impact of Hormonal Contraceptive use upon Women's Social Relationship who att...
Impact of Hormonal Contraceptive use upon Women's Social Relationship who att...
Β 
Female infertility sp
Female infertility spFemale infertility sp
Female infertility sp
Β 
infertility evaluation in detail speroff
infertility evaluation in detail speroffinfertility evaluation in detail speroff
infertility evaluation in detail speroff
Β 
RCT Critical Appraisal - Results
RCT Critical Appraisal - ResultsRCT Critical Appraisal - Results
RCT Critical Appraisal - Results
Β 
AN OPPORTUNITY FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
AN OPPORTUNITY  FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre AN OPPORTUNITY  FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
AN OPPORTUNITY FOR HPV VACCINATION , Dr. Sharda Jain Lifecare Centre
Β 

More from Sax Institute

A model of successful translation
A model of successful translationA model of successful translation
A model of successful translationSax Institute
Β 
How to boost policy and program agencies’ use of research
How to boost policy and program agencies’ use of researchHow to boost policy and program agencies’ use of research
How to boost policy and program agencies’ use of researchSax Institute
Β 
SURE: Helping get the most out of longitudinal data
SURE: Helping get the most out of longitudinal dataSURE: Helping get the most out of longitudinal data
SURE: Helping get the most out of longitudinal dataSax Institute
Β 
Knowledge synthesis for policy and practice
Knowledge synthesis for policy and practiceKnowledge synthesis for policy and practice
Knowledge synthesis for policy and practiceSax Institute
Β 
The 45 and Up Study Update
The 45 and Up Study UpdateThe 45 and Up Study Update
The 45 and Up Study UpdateSax Institute
Β 
Identifying individuals at high risk for lung cancer in Australia
Identifying individuals at high risk for lung cancer in AustraliaIdentifying individuals at high risk for lung cancer in Australia
Identifying individuals at high risk for lung cancer in AustraliaSax Institute
Β 
The geography of walking in Sydney
The geography of walking in SydneyThe geography of walking in Sydney
The geography of walking in SydneySax Institute
Β 
Pathways to lung cancer diagnosis
Pathways to lung cancer diagnosisPathways to lung cancer diagnosis
Pathways to lung cancer diagnosisSax Institute
Β 
The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...Sax Institute
Β 
Evaluation of IC initiatives - challenges, approaches and evaluation of Engla...
Evaluation of IC initiatives - challenges, approaches and evaluation of Engla...Evaluation of IC initiatives - challenges, approaches and evaluation of Engla...
Evaluation of IC initiatives - challenges, approaches and evaluation of Engla...Sax Institute
Β 
Dan Wellings' HARC presentation
Dan Wellings' HARC presentationDan Wellings' HARC presentation
Dan Wellings' HARC presentationSax Institute
Β 
Fidye Westgarth, Agency for Clinical Innovation
Fidye Westgarth, Agency for Clinical InnovationFidye Westgarth, Agency for Clinical Innovation
Fidye Westgarth, Agency for Clinical InnovationSax Institute
Β 
Anne Darton, Agency for Clinical Innovation
Anne Darton, Agency for Clinical InnovationAnne Darton, Agency for Clinical Innovation
Anne Darton, Agency for Clinical InnovationSax Institute
Β 
Bea Brown, Sax Institute
Bea Brown, Sax InstituteBea Brown, Sax Institute
Bea Brown, Sax InstituteSax Institute
Β 
Gai Moore, Sax Institute
Gai Moore, Sax InstituteGai Moore, Sax Institute
Gai Moore, Sax InstituteSax Institute
Β 
Bronwyn Shumack, Clinical Excellence Commission
Bronwyn Shumack, Clinical Excellence CommissionBronwyn Shumack, Clinical Excellence Commission
Bronwyn Shumack, Clinical Excellence CommissionSax Institute
Β 
Carolyn Der Vartanian, (former) Clinical Excellence Commission
Carolyn Der Vartanian, (former) Clinical Excellence CommissionCarolyn Der Vartanian, (former) Clinical Excellence Commission
Carolyn Der Vartanian, (former) Clinical Excellence CommissionSax Institute
Β 
Niek Klazinga | Performance reporting in OECD countries
Niek Klazinga | Performance reporting in OECD countriesNiek Klazinga | Performance reporting in OECD countries
Niek Klazinga | Performance reporting in OECD countriesSax Institute
Β 
Sally Redman | Early findings from SPIRIT
Sally Redman | Early findings from SPIRITSally Redman | Early findings from SPIRIT
Sally Redman | Early findings from SPIRITSax Institute
Β 
Warwick Anderson | Research funding perspectives for CIPHER forum
Warwick Anderson | Research funding perspectives for CIPHER forumWarwick Anderson | Research funding perspectives for CIPHER forum
Warwick Anderson | Research funding perspectives for CIPHER forumSax Institute
Β 

More from Sax Institute (20)

A model of successful translation
A model of successful translationA model of successful translation
A model of successful translation
Β 
How to boost policy and program agencies’ use of research
How to boost policy and program agencies’ use of researchHow to boost policy and program agencies’ use of research
How to boost policy and program agencies’ use of research
Β 
SURE: Helping get the most out of longitudinal data
SURE: Helping get the most out of longitudinal dataSURE: Helping get the most out of longitudinal data
SURE: Helping get the most out of longitudinal data
Β 
Knowledge synthesis for policy and practice
Knowledge synthesis for policy and practiceKnowledge synthesis for policy and practice
Knowledge synthesis for policy and practice
Β 
The 45 and Up Study Update
The 45 and Up Study UpdateThe 45 and Up Study Update
The 45 and Up Study Update
Β 
Identifying individuals at high risk for lung cancer in Australia
Identifying individuals at high risk for lung cancer in AustraliaIdentifying individuals at high risk for lung cancer in Australia
Identifying individuals at high risk for lung cancer in Australia
Β 
The geography of walking in Sydney
The geography of walking in SydneyThe geography of walking in Sydney
The geography of walking in Sydney
Β 
Pathways to lung cancer diagnosis
Pathways to lung cancer diagnosisPathways to lung cancer diagnosis
Pathways to lung cancer diagnosis
Β 
The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...The revised OECD Health Systems Performance Framework: methodological issues ...
The revised OECD Health Systems Performance Framework: methodological issues ...
Β 
Evaluation of IC initiatives - challenges, approaches and evaluation of Engla...
Evaluation of IC initiatives - challenges, approaches and evaluation of Engla...Evaluation of IC initiatives - challenges, approaches and evaluation of Engla...
Evaluation of IC initiatives - challenges, approaches and evaluation of Engla...
Β 
Dan Wellings' HARC presentation
Dan Wellings' HARC presentationDan Wellings' HARC presentation
Dan Wellings' HARC presentation
Β 
Fidye Westgarth, Agency for Clinical Innovation
Fidye Westgarth, Agency for Clinical InnovationFidye Westgarth, Agency for Clinical Innovation
Fidye Westgarth, Agency for Clinical Innovation
Β 
Anne Darton, Agency for Clinical Innovation
Anne Darton, Agency for Clinical InnovationAnne Darton, Agency for Clinical Innovation
Anne Darton, Agency for Clinical Innovation
Β 
Bea Brown, Sax Institute
Bea Brown, Sax InstituteBea Brown, Sax Institute
Bea Brown, Sax Institute
Β 
Gai Moore, Sax Institute
Gai Moore, Sax InstituteGai Moore, Sax Institute
Gai Moore, Sax Institute
Β 
Bronwyn Shumack, Clinical Excellence Commission
Bronwyn Shumack, Clinical Excellence CommissionBronwyn Shumack, Clinical Excellence Commission
Bronwyn Shumack, Clinical Excellence Commission
Β 
Carolyn Der Vartanian, (former) Clinical Excellence Commission
Carolyn Der Vartanian, (former) Clinical Excellence CommissionCarolyn Der Vartanian, (former) Clinical Excellence Commission
Carolyn Der Vartanian, (former) Clinical Excellence Commission
Β 
Niek Klazinga | Performance reporting in OECD countries
Niek Klazinga | Performance reporting in OECD countriesNiek Klazinga | Performance reporting in OECD countries
Niek Klazinga | Performance reporting in OECD countries
Β 
Sally Redman | Early findings from SPIRIT
Sally Redman | Early findings from SPIRITSally Redman | Early findings from SPIRIT
Sally Redman | Early findings from SPIRIT
Β 
Warwick Anderson | Research funding perspectives for CIPHER forum
Warwick Anderson | Research funding perspectives for CIPHER forumWarwick Anderson | Research funding perspectives for CIPHER forum
Warwick Anderson | Research funding perspectives for CIPHER forum
Β 

Recently uploaded

Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Β 
Russian Escorts Girls Nehru Place ZINATHI πŸ”9711199012 β˜ͺ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI πŸ”9711199012 β˜ͺ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI πŸ”9711199012 β˜ͺ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI πŸ”9711199012 β˜ͺ 24/7 Call Girls DelhiAlinaDevecerski
Β 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Β 
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
Β 
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
Β 
πŸ’ŽVVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
πŸ’ŽVVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...πŸ’ŽVVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
πŸ’ŽVVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...Taniya Sharma
Β 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...parulsinha
Β 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Genuine Call Girls
Β 
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...narwatsonia7
Β 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...perfect solution
Β 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...astropune
Β 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Β 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Servicevidya singh
Β 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...indiancallgirl4rent
Β 
VIP Service Call Girls Sindhi Colony πŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony πŸ“³ 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony πŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony πŸ“³ 7877925207 For 18+ VIP Call Girl At Th...jageshsingh5554
Β 
Call Girls Bareilly Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Bareilly Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 8250077686 Top Class Call Girl Service AvailableDipal Arora
Β 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Β 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escortsvidya singh
Β 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeCall Girls Delhi
Β 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableDipal Arora
Β 

Recently uploaded (20)

Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Ludhiana Just Call 9907093804 Top Class Call Girl Service Available
Β 
Russian Escorts Girls Nehru Place ZINATHI πŸ”9711199012 β˜ͺ 24/7 Call Girls Delhi
Russian Escorts Girls  Nehru Place ZINATHI πŸ”9711199012 β˜ͺ 24/7 Call Girls DelhiRussian Escorts Girls  Nehru Place ZINATHI πŸ”9711199012 β˜ͺ 24/7 Call Girls Delhi
Russian Escorts Girls Nehru Place ZINATHI πŸ”9711199012 β˜ͺ 24/7 Call Girls Delhi
Β 
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Varanasi Just Call 9907093804 Top Class Call Girl Service Available
Β 
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Tirupati Just Call 8250077686 Top Class Call Girl Service Available
Β 
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Ooty Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Ooty Just Call 8250077686 Top Class Call Girl Service Available
Β 
πŸ’ŽVVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
πŸ’ŽVVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...πŸ’ŽVVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
πŸ’ŽVVIP Kolkata Call Girls Parganas🩱7001035870🩱Independent Girl ( Ac Rooms Avai...
Β 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
Β 
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Pondicherry Call Girls Book Now 9630942363 Top Class Pondicherry Escort Servi...
Β 
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟  9332606886 ⟟ Call Me For G...
Top Rated Bangalore Call Girls Ramamurthy Nagar ⟟ 9332606886 ⟟ Call Me For G...
Β 
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
College Call Girls in Haridwar 9667172968 Short 4000 Night 10000 Best call gi...
Β 
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Β 
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Coimbatore Just Call 9907093804 Top Class Call Girl Service Available
Β 
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort ServicePremium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Premium Call Girls Cottonpet Whatsapp 7001035870 Independent Escort Service
Β 
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
(Rocky) Jaipur Call Girl - 09521753030 Escorts Service 50% Off with Cash ON D...
Β 
VIP Service Call Girls Sindhi Colony πŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony πŸ“³ 7877925207 For 18+ VIP Call Girl At Th...VIP Service Call Girls Sindhi Colony πŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
VIP Service Call Girls Sindhi Colony πŸ“³ 7877925207 For 18+ VIP Call Girl At Th...
Β 
Call Girls Bareilly Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 8250077686 Top Class Call Girl Service AvailableCall Girls Bareilly Just Call 8250077686 Top Class Call Girl Service Available
Call Girls Bareilly Just Call 8250077686 Top Class Call Girl Service Available
Β 
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Dehradun Just Call 9907093804 Top Class Call Girl Service Available
Β 
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore EscortsCall Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Call Girls Horamavu WhatsApp Number 7001035870 Meeting With Bangalore Escorts
Β 
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any TimeTop Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Top Quality Call Girl Service Kalyanpur 6378878445 Available Call Girls Any Time
Β 
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service AvailableCall Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Call Girls Faridabad Just Call 9907093804 Top Class Call Girl Service Available
Β 

Kirsten McCaffery | Improving health literacy: what's the evidence?

  • 1. IMPROVING HEALTH LITERACY: What is the evidence ? Kirsten McCaffery PhD kirsten.mccaffery@sydney.edu.au SYDNEY MEDICAL SCHOOL Screening and Test Evaluation Program (STEP) Centre for Medical Psychology and Evidence-based Decision Making (CeMPED)
  • 2. IMPROVING HEALTH LITERACY  Substantial research linking low health literacy with poor health  Intervention health literacy research is less well developed  3 systematic reviews of health literacy interventions but findings mixed (Pignone JGIM 2005, Coulter & Ellins BMJ 2007, Clement et al PEC 2009)  However, there IS evidence to guide policy and practice now  Evidence from low literacy and general population samples
  • 3. IMPROVING HEALTH LITERACY Two key areas for evidence-based action: 1. To improve health communication 2. To support patient involvement
  • 4. IMPROVING HEALTH LITERACY Two key areas for evidence-based action: 1. To improve health communication 2. To support patient involvement
  • 5. IMPROVING HEALTH LITERACY There is good quality evidence to support strategies to improve : a. Written health information – use plain language guides b. Prescription drug labels – use precise instructions c. Verbal communication – use β€˜teach back’ method d. Risk communication
  • 6. IMPROVING HEALTH LITERACY There is good quality evidence to support strategies to improve : a. Written health information – use plain language guides b. Prescription drug labels – use precise instructions c. Verbal communication – use β€˜teach back’ method d. Risk communication
  • 7. RISK COMMUNICATION Use natural frequencies 5 out of 100 women will require additional treatment Gigerenzer et al 1995, Feldman-Stewart et al 2000, Fagerlin et al review 2007
  • 8. RISK COMMUNICATION Of 100 women who have surgery ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● 5 out of 100 women will require additional treatment Gigerenzer et al 1995, Feldman-Stewart et al 2000, Fagerlin et al review 2007
  • 9. RISK COMMUNICATION Of 100 women who 20% less women will have surgery required additional treatment 5% of women will ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● NOT required additional ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● treatment ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● 5 out of 100 women will require additional treatment Gigerenzer et al 1995, Feldman-Stewart et al 2000, Fagerlin et al review 2007
  • 10. RISK COMMUNICATION Of 100 women who 20% less women will have surgery required additional treatment 5% of women will ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● NOT required additional ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● treatment ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● OR ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● 100 90 80 70 60 50 40 30 5 out of 100 women 20 10 0 will require additional treatment Gigerenzer et al 1995, Feldman-Stewart et al 2000, Fagerlin et al review 2007
  • 11. RISK COMMUNICATION Medical risk training for low and high SES consumers Woloshin et al Annals Intern Med 2007  Education package to improve understanding of risk messages in the media and health statistics  2 RCTs among low and high SES consumers  Medical risk primer vs general health booklet (control)  Examined impact using knowledge test
  • 12. RISK COMMUNICATION Impact of the primer on understanding Patient group Control gp Risk Primer % Difference Significance β€˜pass rate’ β€˜pass rate’ (95% CIs) Pass β‰₯ 75 / 100 correct
  • 13. RISK COMMUNICATION Impact of the primer on understanding Patient group Control gp Risk Primer % Difference Significance β€˜pass rate’ β€˜pass rate’ (95% CIs) Low SES 26% 44% 18% p<0.01 n= 221 (8-28%) Pass β‰₯ 75 / 100 correct
  • 14. RISK COMMUNICATION Impact of the primer on understanding Patient group Control gp Risk Primer % Difference Significance β€˜pass rate’ β€˜pass rate’ (95% CIs) Low SES 26% 44% 18% p<0.01 n= 221 (8-28%) High SES 56% 74% 18% p<0.001 n=334 (5-31%) Pass β‰₯ 75 / 100 correct
  • 15. RISK COMMUNICATION Impact of the primer on understanding Patient group Control gp Risk Primer % Difference Significance β€˜pass rate’ β€˜pass rate’ (95% CIs) Low SES 26% 44% 18% p<0.01 n= 221 (8-28%) High SES 56% 74% 18% p<0.001 n=334 (5-31%) Pass β‰₯ 75 / 100 correct
  • 16. RISK COMMUNICATION Impact of the primer on understanding Patient group Control gp Risk Primer % Difference Significance β€˜pass rate’ β€˜pass rate’ (95% CIs) Low SES 26% 44% 18% p<0.01 n= 221 (8-28%) High SES 56% 74% 18% p<0.001 n=334 (5-31%) Pass β‰₯ 75 / 100 correct Interest in medical statistics significantly increased in both groups Low SES = + 8 points (p=0.004) High SES = + 6 points (p=0.004)
  • 17. IMPROVING HEALTH LITERACY Two key areas for evidence based action: 1. To improve health communication 2. To support patient involvement β€’ Broader definition of health literacy (asset) β€’ Fits within model of Patient Centred Care and Shared Decision Making β€’ Highlighted in National Health Hospital Reform Commission Report
  • 18. IMPROVING HEALTH LITERACY Effective tools are available to support patient involvement and engagement in healthcare. 2 main types: a. Patient Decision Aids b. Intervention to promote question asking (Question Prompt Lists (QPL) / patient coaching)
  • 19. PATIENT DECISION AIDS What are patient decision aids?  Information designed to help patients make an informed choice consistent with their preferences  Booklet / video/ audio / web-based form  Include evidence based information on options and outcomes  Exercises to help patients clarify values
  • 20. PATIENT DECISION AIDS Patient decision aids are very effective. Systematic review of 55 DA trials showed DAs:  Improve patient knowledge and understanding of risks and benefits  Increase realistic expectations of outcomes  Reduce uncertainty in decision making  Increase consistency between patients’ values and choice  Without increasing in patient anxiety
  • 21. PATIENT DECISION AIDS In some circumstances decision aids:  Increase adherence  Reduce unnecessary testing/ medical procedures  Increase quality of life (O’Connor et al. Cochrane Review 2009)
  • 22. QUESTION ASKING INTERVENTIONS What are Question Asking Interventions? Interventions to encourage patients to ask questions and direct the content of the consultation towards their needs and concerns
  • 23. QUESTION ASKING INTERVENTIONS What are Question Asking Interventions? Interventions to encourage patients to ask questions and direct the content of the consultation towards their needs and concerns
  • 24. QUESTION ASKING INTERVENTIONS Kinnersley et al Cochrane review (2007) Question Asking Interventions  Increased question asking  Increased patient satisfaction (small increase)  No increase in anxiety  No increase in consultation length In some studies QPLs  Enabled participants to raise more β€˜sensitive’ issues during the consultation (Clayton et al 2007)
  • 25. INVOLVING LOW LITERACY PATIENTS  Excellent evidence that DAs and QPLs support patient involvement and improve health decisions  But very little research with low literacy and low education groups  These groups are least involved in healthcare, most difficult to get to participate, form large % patient population  However, we recently completed a RCT β€˜lower literacy’ DA among adults with low education
  • 26. FOBT SCREENING LOWER LITERACY DA McCaffery et al NHMRC project grant, Sian Smith et al PhD. [Full project team: K McCaffery, S Smith, L Trevena, A Barratt, J Simpson, D Nutbeam]
  • 27. Trial design Community sample: adults 55-64 years n= 585 Lower education levels* Control: Decision Aid Govt screening booklet FOBT screening kit FOBT screening kit Knowledge Informed choice 2 weeks * No formal educ Involvement in decision making qualifications, intermediate Psychosocial outcomes school certificate, technical/ trade qualification Screening behaviour 3 months (FOBT completion)
  • 28. Low education/ literacy DA trial: results  DA increased adequate knowledge by 38% (56% DAs vs control 18%)  DA increased in informed choice by 22% (adequate knowledge, choice consistent with attitudes 34% DA vs 12% control)  DA increased preferences for shared decision making (P=0.04)  No difference in uncertainty in decision making and anxiety - low in both groups  Acceptability of DA high (>90%) (Smith et al BMJ under review)
  • 29. CONCLUSIONS  Possible to design DAs to help low education / low health literacy consumers make informed choices  Even though this involves communicating complicated medical information  More research supporting patient involvement in low health literacy groups  Although field is rapidly developing, evidence available to support action now: οƒΌ Written health communication οƒΌ Prescription drug labels οƒΌ Verbal communication οƒΌ Risk communication οƒΌ Supporting patient involvement
  • 30. Goal for Public Health & Medicine Patient skills Evidence + + Health system CLOSE THE GAP Practice Particular thanks to: Sian Smith
  • 31.
  • 32. EFFECTIVE HEALTH COMMUNICATION Prescription drug labels  US study of 400 native English speaking primary care patients, lower SES.  50% misunderstood commonly used prescription labels (Davies et al Archives 2006)  Understanding improved 53% - 89% correct, if instructions are precise and explicit (Davies et al JGIM 2008)  E.g.  β€˜Take at 6am and 6pm’ or  β€˜take 1 with breakfast and 1 with supper’  NOT β€˜take twice daily’ or β€˜take every 12 hours’
  • 33. CONSUMERS / PATIENT NEEDS So why does SDM matter?:  Consumers want more health information and involvement in health decisions  European survey of over 8,000 consumers (Coulter BJC 2003)  Over 70% of those surveyed wanted β€˜shared decision making’  In Australia our own work has reported similar high levels of interest in SDM in breast treatment and testing decisions (Davey, Barratt et al 2002)
  • 34. IMPROVING HEALTH LITERACY There is good quality evidence to support strategies to improve : a. Written health information – use plain language guides b. Prescription drug labels – use precise instructions c. Verbal communication – use β€˜teach back’ method d. Risk communication – natural frequencies
  • 35. RISK COMMUNICATION Key topics  Risk of what?  How big is the risk?  Does the risk information reasonably apply to you?  How does this compare to other risks?  Things you should do to better understand risk…..
  • 36. Trials of cancer screening decision aids (DAs) Screening Countr Study population and Description Primary % Adeq % Screened % Informed choice context and y recruitment outcomes knowldge DA vs Control DA vs Control author(s) measured DA vs (difference) (difference) Control (diff) FOBT screening Aus Men and women aged DA tailored for adults with lower Knowledge 56 vs 19 59 vs 75 34 vs 12 for bowel cancer between 55-64 years with education and literacy with Informed (38) ** (-16) ** (22) ** (Smith, et al. lower education levels government information booklet choice 2009) Involvement in decision Mammog Aus Women aged 70 years or DA with usual care information Knowledge 77 vs 57 6 vs 7 74 vs 49 screening for older , regularly (leaflet developed for breast Informed (20) ** (-1) (25)** breast cancer participated in cancer screening service). choice mammography screening. (Mathieu, et al. Participation 2007) in screening FOBT screening Aus Adults aged between 45- DA against standard government Knowledge 21 vs 6 5 vs 7 10 vs 2 for bowel cancer 74 yrs at GP practice information booklet. Informed (15)** (-2) (8)** (Trevena et al choice 2008) FOBT and US Adults aged 65 years and 2 DAs (one relative risk info and Screening 71 vs 54 Intentions N/A flexible sig for older visiting their primary the other with absolute risk infor) interest and (17)** Control: 59; CRC (Wolf et al care doctor against control message. intentions 2000) Rel risk DA: 67; Abs risk DA: 63 FOBT, flex sig, US Adults aged 50 years and Compared DA based on multi- Decisional N/A 49 vs 52 N/A barium en, older, visiting their primarycriteria decision-making theory conflict (-3) colonos for care doctor with a simple educational Screening CRC (Dolan et al intervention. intentions and 2002) behaviour FOBT and US Adults aged between 50- Educational video about bowel Screening N/A 37 vs 23 N/A Fleixble sig 75 years from primary screening with video on behaviour (14)** (Pignone et al care. automobile safety (control group). 2000)